IBDEI0GD ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7949,0)
 ;;=173.10^^58^604^56
 ;;^UTILITY(U,$J,358.3,7949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7949,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Unspec
 ;;^UTILITY(U,$J,358.3,7949,1,4,0)
 ;;=4^173.10
 ;;^UTILITY(U,$J,358.3,7949,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,7950,0)
 ;;=173.11^^58^604^53
 ;;^UTILITY(U,$J,358.3,7950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7950,1,3,0)
 ;;=3^Eyelid/Canthus,BCC
 ;;^UTILITY(U,$J,358.3,7950,1,4,0)
 ;;=4^173.11
 ;;^UTILITY(U,$J,358.3,7950,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,7951,0)
 ;;=173.12^^58^604^57
 ;;^UTILITY(U,$J,358.3,7951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7951,1,3,0)
 ;;=3^Eyelid/Canthus,SCC
 ;;^UTILITY(U,$J,358.3,7951,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,7951,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,7952,0)
 ;;=173.19^^58^604^55
 ;;^UTILITY(U,$J,358.3,7952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7952,1,3,0)
 ;;=3^Eyelid/Canthus,Malig Neopl,Oth
 ;;^UTILITY(U,$J,358.3,7952,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,7952,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,7953,0)
 ;;=053.20^^58^604^51
 ;;^UTILITY(U,$J,358.3,7953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7953,1,3,0)
 ;;=3^Eyelid,Herpes Zoster
 ;;^UTILITY(U,$J,358.3,7953,1,4,0)
 ;;=4^053.20
 ;;^UTILITY(U,$J,358.3,7953,2)
 ;;=^56937
 ;;^UTILITY(U,$J,358.3,7954,0)
 ;;=054.41^^58^604^50
 ;;^UTILITY(U,$J,358.3,7954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7954,1,3,0)
 ;;=3^Eyelid,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,7954,1,4,0)
 ;;=4^054.41
 ;;^UTILITY(U,$J,358.3,7954,2)
 ;;=^266563
 ;;^UTILITY(U,$J,358.3,7955,0)
 ;;=078.0^^58^604^77
 ;;^UTILITY(U,$J,358.3,7955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7955,1,3,0)
 ;;=3^Molluscum Contagiosum
 ;;^UTILITY(U,$J,358.3,7955,1,4,0)
 ;;=4^078.0
 ;;^UTILITY(U,$J,358.3,7955,2)
 ;;=^78675
 ;;^UTILITY(U,$J,358.3,7956,0)
 ;;=228.1^^58^604^76
 ;;^UTILITY(U,$J,358.3,7956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7956,1,3,0)
 ;;=3^Lymphangioma
 ;;^UTILITY(U,$J,358.3,7956,1,4,0)
 ;;=4^228.1
 ;;^UTILITY(U,$J,358.3,7956,2)
 ;;=^72391
 ;;^UTILITY(U,$J,358.3,7957,0)
 ;;=238.2^^58^604^3
 ;;^UTILITY(U,$J,358.3,7957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7957,1,3,0)
 ;;=3^Benign Neopl,Oth & Unspec Sites/Tissue
 ;;^UTILITY(U,$J,358.3,7957,1,4,0)
 ;;=4^238.2
 ;;^UTILITY(U,$J,358.3,7957,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,7958,0)
 ;;=242.00^^58^604^61
 ;;^UTILITY(U,$J,358.3,7958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7958,1,3,0)
 ;;=3^Goiter Toxic Dif/Graves Thyrotoxic Exoph
 ;;^UTILITY(U,$J,358.3,7958,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,7958,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,7959,0)
 ;;=272.2^^58^604^101
 ;;^UTILITY(U,$J,358.3,7959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7959,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,7959,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,7959,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,7960,0)
 ;;=360.40^^58^604^60
 ;;^UTILITY(U,$J,358.3,7960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7960,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,7960,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,7960,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,7961,0)
 ;;=360.42^^58^604^65
 ;;^UTILITY(U,$J,358.3,7961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7961,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,7961,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,7961,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,7962,0)
 ;;=360.89^^58^604^59
 ;;^UTILITY(U,$J,358.3,7962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7962,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,7962,1,4,0)
 ;;=4^360.89
